The Valley Desk

NCT01997229 · Interventional trial

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

Overall registry status Completed

Phase 3

Conditions Refractory Generalized Myasthenia Gravis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov